Patients with chronic kidney disease and metabolic acidosis treated with sodium bicarbonate experienced decreased risks of a doubling of serum creatinine, initiation of renal replacement therapy, and death.
The expression of interferon-related genes in tumor specimens was associated with response to neoadjuvant immune checkpoint inhibitor-based therapy.
Long-term survival of kidney transplant recipients is similar regardless of donor gender, British investigators report.
Outside of clinical trials, targeted therapies for advanced renal cell carcinoma in Medicare patients are associated with modest survival advantages over non-targeted therapies.
In a nationwide study, one fifth of surgeons had high AVG use rates, exceeding the guidelines threshold of 34%.
In a study of chronic kidney disease patients not on dialysis, hyperkalemia developed in more women than men.
Proton pump inhibitor use by patients with CKD stage 3 to 5 is associated with 54% and 35% increased risks of acute kidney injury and death, respectively, a study found.
In a small study, 34% of dialysis patients had vertebral fractures, and patients in the highest tertile of parathyroid hormone level had a nearly 3-fold increased risk of these fractures compared with those in the middle tertile.
Compared with CKD stage 3a, CKD stages 3b, 4, and 5 were associated with significant 1.5-, 2.4-, and 5.4-fold increased risks of anemia.
New data support aggressive vitamin D repletion to a revised serum 25-hydroxyvitamin D target of at least 51 ng/mL in patients with chronic kidney disease.